Simulating CD8 T cell exhaustion: A comprehensive approach

Andrea J Manrique-Rincón1,2,3, Ben Foster1,3, Stuart Horswell2,3

  • 1Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, UK.

Iscience
|July 18, 2025
PubMed

Insights

Researchers developed a new model to study T cell exhaustion in cancer immunotherapy. This model helps identify genes to reverse T cell exhaustion and improve patient treatment outcomes.

Area of Science:

  • Immunology
  • Cancer Biology
  • T cell biology

Background:

  • Immunotherapy has revolutionized cancer treatment but lacks predictive biomarkers for patient response.
  • A subset of CD8 T cells exhibits an exhausted phenotype, impairing anti-tumor immunity.

Purpose of the Study:

  • To develop reproducible models for identifying therapeutic targets to reverse T cell exhaustion.
  • To characterize the hallmarks of T cell exhaustion and discover a shared gene signature.

Main Methods:

  • Development of an in vitro model using chronic antigen stimulation of T cells.
  • Temporal phenotypic characterization of T cells in vitro and validation in vivo models.
  • Identification of a gene signature associated with exhausted T cell states.

Main Results:

  • The in vitro model recapitulates key features of T cell exhaustion, including impaired function and altered metabolism.
  • A shared gene signature was identified between in vitro and in vivo exhausted T cells.
  • This gene signature is present in tumor-infiltrating T cells from various human cancers.

Conclusions:

  • The developed model is a valuable tool for discovering novel therapies to overcome T cell exhaustion.
  • The identified gene signature holds translational potential for improving cancer immunotherapy efficacy.

Related Concept Videos